Xiaoyan Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaoyan Duan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Chunmei Wang
Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
1 shared publication- Jianbo Li
Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People’s Republic of China
1 shared publication Pinghui Li
Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
1 shared publicationWenrui Wang
Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
1 shared publication
Latest Publications
- Open Access
- 22 February 2023
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 332 (6) , 2279-2284
Preliminary evaluation of a 64Cu-labeled DNA aptamer for PET imaging of glioblastoma
To develop a DNA aptamer-based PET tracer for imaging of glioblastoma. 5 mM of NOTA-AS1411, 60-min, and 37 °C were selected as the optimal condition for 64Cu radiolabeling of AS1411. 64Cu-NOTA-AS1411 remained stable in PBS and 100% mouse serum for at least six hours. From the PET images, 64Cu-NOTA-AS1411 tended to be excreted out through the kidneys and there was high tracer accumulation in the bladder. There was a higher tumor uptake in the AS1411 group than that in the control group. 64Cu-NOTA-AS1411 is a suitable potential PET tracer for imaging murine glioblastoma.
- 22 February 2023
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 332 (6) , 2279-2284
Open AccessPreliminary evaluation of a 64Cu-labeled DNA aptamer for PET imaging of glioblastoma
To develop a DNA aptamer-based PET tracer for imaging of glioblastoma. 5 mM of NOTA-AS1411, 60-min, and 37 °C were selected as the optimal condition for 64Cu radiolabeling of AS1411. 64Cu-NOTA-AS1411 remained stable in PBS and 100% mouse serum for at least six hours. From the PET images, 64Cu-NOTA-AS1411 tended to be excreted out through the kidneys and there was high tracer accumulation in the bladder. There was a higher tumor uptake in the AS1411 group than that in the control group. 64Cu-NOTA-AS1411 is a suitable potential PET tracer for imaging murine glioblastoma.